OXM

OXM Net Receivables

$74.72MQuarterly · USD

Period ending:

OXM FY Net ReceivablesUSD
OXM FY Net Receivables1986-05-31: $64.30M1987-05-31: $72.90M1988-05-31: $75.80M1989-05-31: $72.00M1990-05-31: $74.10M1991-05-31: $59.70M1992-05-31: $67.20M1993-05-31: $68.10M1994-06-03: $75.20M1995-06-02: $84.00M1996-05-31: $84.60M1997-05-30: $77.80M1998-05-29: $100.80M1999-05-28: $114.70M2000-06-02: $119.60M2001-06-01: $50.70M2002-05-31: $103.20M2003-05-30: $110.30M2004-05-28: $176.37M2005-06-03: $197.09M2006-06-02: $142.30M2007-06-01: $138.04M2008-01-31: $105.56M2009-01-31: $78.57M2010-01-30: $74.40M2011-01-29: $50.18M2012-01-28: $59.71M2013-02-02: $62.81M2014-02-01: $75.28M2015-01-31: $79.10M2016-01-30: $59.07M2017-01-28: $58.28M2018-02-03: $67.54M2019-02-02: $69.04M2020-02-01: $58.72M2021-01-30: $48.39M2022-01-29: $54.28M2023-01-28: $63.43M2024-02-03: $82.91M2025-02-01: $77.76M2026-01-31: $72.96M$197.09M$0.00
1986-05-312026-01-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

OXM net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 41 observations from May 31, 1986 to Jan 31, 2026.

Oxford Industries Inc Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
72,957,000
77,756,000
82,911,000
63,426,000
54,278,000
48,393,000
58,724,000
69,037,000
67,542,000
58,279,000
59,065,000
79,104,000
75,277,000
62,805,000
59,706,000
50,177,000
74,398,000
78,567,000
105,561,000
138,035,000
142,297,000
197,094,000
176,367,000
110,304,000
103,198,000
50,699,000
119,597,000
114,700,000
100,800,000
77,800,000
84,600,000
84,000,000
75,200,000
68,100,000
67,200,000
59,700,000
74,100,000
72,000,000
75,800,000
72,900,000
64,300,000

Compare net receivables

All OXM financial metrics · OXM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.